Fundraising Fox

Pharmaron

5 known investors

pharmaron.com β†—

Pharmaron is a life science contract research and manufacturing service provider covering drug discovery, preclinical and clinical development, and commercialization. It serves pharmaceutical and biotech partners across small molecules, biologics, and cell and gene therapy (CGT) products.

BiotechHealthtechMedical Devices

Investors Β· 5

Aisling CapitalNew York
DCM VenturesMenlo Park Β· $250K – $15M
Scientia VenturesNew York
DCMreportedNew York
Legend CapitalreportedBeijing Β· $2.9M – $156M

Funding

SEC filings, press & company announcements

Source: company announcements and press reports β€” follow each round's link for the claim.

In the news

/C O R R E C T I O N -- BridGene Biosciences/prnewswire.com Β· Jan 2026Pharmaron Raises HK$1.32 Billion via H-Share Placement to Fund Capacity Expansionlongbridge.com Β· Jan 2026Pharmaron Is Said to Raise $589 Million in Hong Kong Listing - Bloombergbloomberg.com Β· Nov 2019The Week in Review: Pharmaron LLC Raises $40 Million in Venture Capital - BioSpacebiospace.com Β· Feb 2011Pharmaron raises $40m -globalventuring.com Β· Feb 2011New Investment Into Pharmaron Positions The Company For Future Growth - Pharmaronpharmaron.com

Frequently asked questions

What does Pharmaron do?
Pharmaron is a life science contract research and manufacturing service provider covering drug discovery, preclinical and clinical development, and commercialization. It serves pharmaceutical and biotech partners across small molecules, biologics, and cell and gene therapy (CGT) products.
Who are Pharmaron's investors?
Pharmaron's investors include Aisling Capital, DCM Ventures, Scientia Ventures, DCM, Legend Capital.